Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1864 1
1866 1
1867 1
1872 1
1887 1
1891 2
1912 1
1913 2
1914 1
1915 2
1916 1
1917 1
1918 2
1919 1
1923 1
1947 2
1959 1
1960 1
1962 3
1967 2
1968 3
1969 2
1971 3
1972 3
1973 3
1974 3
1976 2
1980 1
1981 2
1983 3
1984 2
1986 1
1987 2
1989 2
1990 2
1991 1
1992 4
1993 3
1994 3
1995 2
1996 4
1997 2
1998 6
1999 4
2000 4
2001 1
2002 6
2003 5
2004 7
2005 9
2006 15
2007 9
2008 12
2009 7
2010 16
2011 22
2012 20
2013 8
2014 12
2015 13
2016 14
2017 14
2018 9
2019 10
2020 10
2021 12
2022 12
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.
National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network; Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D, Hough CL, Huang W, Iwashyna TJ, Jones AE, Khan A, Lai P, Liu KD, Miller CD, Oldmixon K, Park PK, Rice TW, Ringwood N, Semler MW, Steingrub JS, Talmor D, Thompson BT, Yealy DM, Self WH. National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network, et al. N Engl J Med. 2023 Feb 9;388(6):499-510. doi: 10.1056/NEJMoa2212663. Epub 2023 Jan 21. N Engl J Med. 2023. PMID: 36688507 Free PMC article. Clinical Trial.
Rethinking agrochemical safety assessment: A perspective.
Sewell F, Lewis D, Mehta J, Terry C, Kimber I. Sewell F, et al. Among authors: terry c. Regul Toxicol Pharmacol. 2021 Dec;127:105068. doi: 10.1016/j.yrtph.2021.105068. Epub 2021 Oct 19. Regul Toxicol Pharmacol. 2021. PMID: 34678328 Free article. Review.
Editorial: Chemical testing using new approach methodologies (NAMs).
Stucki AO, Clippinger AJ, Henry TR, Hirn C, Stedeford TJ, Terry C. Stucki AO, et al. Among authors: terry c. Front Toxicol. 2022 Nov 10;4:1048900. doi: 10.3389/ftox.2022.1048900. eCollection 2022. Front Toxicol. 2022. PMID: 36438078 Free PMC article. No abstract available.
The Emerging Issue of Digital Empathy.
Terry C, Cain J. Terry C, et al. Am J Pharm Educ. 2016 May 25;80(4):58. doi: 10.5688/ajpe80458. Am J Pharm Educ. 2016. PMID: 27293225 Free PMC article. Review.
Beyond Bioextraction: The Role of Oyster-Mediated Denitrification in Nutrient Management.
Ayvazian S, Mulvaney K, Zarnoch C, Palta M, Reichert-Nguyen J, McNally S, Pilaro M, Jones A, Terry C, Fulweiler RW. Ayvazian S, et al. Among authors: terry c. Environ Sci Technol. 2021 Nov 2;55(21):14457-14465. doi: 10.1021/acs.est.1c01901. Epub 2021 Oct 21. Environ Sci Technol. 2021. PMID: 34672569 Free PMC article. Review.
The martial arts.
Terry CM. Terry CM. Phys Med Rehabil Clin N Am. 2006 Aug;17(3):645-76. doi: 10.1016/j.pmr.2006.05.001. Phys Med Rehabil Clin N Am. 2006. PMID: 16952757 Review.
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Brown SM, Barkauskas CE, Grund B, Sharma S, Phillips AN, Leither L, Peltan ID, Lanspa M, Gilstrap DL, Mourad A, Lane K, Beitler JR, Serra AL, Garcia I, Almasri E, Fayed M, Hubel K, Harris ES, Middleton EA, Barrios MAG, Mathews KS, Goel NN, Acquah S, Mosier J, Hypes C, Salvagio Campbell E, Khan A, Hough CL, Wilson JG, Levitt JE, Duggal A, Dugar S, Goodwin AJ, Terry C, Chen P, Torbati S, Iyer N, Sandkovsky US, Johnson NJ, Robinson BRH, Matthay MA, Aggarwal NR, Douglas IS, Casey JD, Hache-Marliere M, Georges Youssef J, Nkemdirim W, Leshnower B, Awan O, Pannu S, O'Mahony DS, Manian P, Awori Hayanga JW, Wortmann GW, Tomazini BM, Miller RF, Jensen JU, Murray DD, Bickell NA, Zatakia J, Burris S, Higgs ES, Natarajan V, Dewar RL, Schechner A, Kang N, Arenas-Pinto A, Hudson F, Ginde AA, Self WH, Rogers AJ, Oldmixon CF, Morin H, Sanchez A, Weintrob AC, Cavalcanti AB, Davis-Karim A, Engen N, Denning E, Taylor Thompson B, Gelijns AC, Kan V, Davey VJ, Lundgren JD, Babiker AG, Neaton JD, Lane HC; ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group. Brown SM, et al. Among authors: terry c. Lancet Respir Med. 2023 Sep;11(9):791-803. doi: 10.1016/S2213-2600(23)00147-9. Epub 2023 Jun 19. Lancet Respir Med. 2023. PMID: 37348524 Clinical Trial.
323 results